Linezolid for the Treatment of Urinary Tract Infections Caused by Vancomycin-Resistant Enterococci
Vancomycin-resistant enterococci (VRE) account for a large proportion of hospital-acquired infections. Determining optimal treatment of VRE urinary tract infections (UTIs) is challenging. The purpose of this study was to determine if a difference in efficacy or safety exists between linezolid and no...
| Автори: | , , , , , |
|---|---|
| Формат: | Стаття |
| Мова: | English |
| Опубліковано: |
MDPI AG
2021-10-01
|
| Серія: | Pharmacy |
| Предмети: | |
| Онлайн доступ: | https://www.mdpi.com/2226-4787/9/4/175 |